Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR

Rang în acțiuni #36453
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Preț acțiune
$1.73
Ultima sincronizare: 2025-06-17
Capitalizare de piață
$2.55M
Schimbare (1 zi)
-0.29%
Schimbare (1 an)
-79.71%
Țară
US
Tranzacționează Eiger BioPharmaceuticals, Inc. (EIGR)

Categorie

Healthcare
Istoricul spliturilor pentru Eiger BioPharmaceuticals, Inc. (EIGR)
Acțiunea Eiger BioPharmaceuticals, Inc. (simbol: EIGR) a trecut printr-un total de 2 splituri.
Cel mai recent split a avut loc pe Jan 08, 2024.
O acțiune EIGR cumpărată înainte de Mar 23, 2016 este echivalentă astăzi cu 0.0022222222222222 acțiuni EIGR.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
2024-01-08 1:30 x0.033333333333333 x0.0022222222222222
2016-03-23 1:15 x0.066666666666667 x0.066666666666667
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL